https://www.selleckchem.com/pr....oducts/o-pentagalloy
According to data from the American Cancer Society, cancer is one of the deadliest health problems globally. Annually, renal cell carcinoma (RCC) causes more than 100,000 deaths worldwide [1-4], posing an urgent need to develop effective treatments to increase patient survival outcomes. New therapies are expected to address a major factor contributing to cancer's resistance to standard therapies oncogenic heterogeneity. Gene expression can vary tremendously among different types of cancers, different patients of the same t
Like
Comment
Share
